p60TRP Activators
The activation of p60TRP relies on various biochemical mechanisms that modulate intracellular signaling pathways. One mechanism involves the elevation of intracellular cAMP levels, which is achieved through the direct stimulation of adenylyl cyclase or through the inhibition of phosphodiesterases, leading to the accumulation of cAMP. This increase in cAMP levels activates PKA, which can phosphorylate p60TRP, thereby enhancing its activity. Furthermore, the activation of β-adrenergic receptors also raises cAMP levels, employing a similar activation mechanism. Additionally, the artificial elevation of cAMP using a membrane-permeable analog directly activates PKA, leading to potential phosphorylation events that increase p60TRP activity.
Another set of mechanisms centers around the modulation of intracellular calcium levels. Compounds that act as calcium ionophores or those that inhibit the SARCO/ER Ca2+-ATPase pump cause an increase in cytosolic calcium, which can activate downstream calcium-dependent kinases. These kinases, in turn, have the potential to increase p60TRP activity as part of calcium-mediated signaling pathways. Furthermore, the activation of L-type calcium channels contributes to the increase in intracellular calcium, which can similarly affect p60TRP activity. Activation of vanilloid receptors also leads to increased intracellular calcium levels, again potentially enhancing p60TRP activity. Additionally, the indirect activation of the MAPK pathway through the inhibition of protein synthesis may lead to an increase in p60TRP activity as part of the cellular stress response. Moreover, modulators of the PKC pathway can lead to compensatory regulatory mechanisms that may also result in the increased activity of p60TRP.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Directly stimulates adenylyl cyclase, increasing cAMP levels. Elevated cAMP can enhance p60TRP activity by cAMP-dependent protein kinase (PKA) phosphorylation, which may lead to changes in cellular responses regulated by p60TRP. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, preventing cAMP breakdown, which supports the accumulation of cAMP in the cell and can enhance p60TRP activity through the PKA signaling pathway. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which can phosphorylate p60TRP, potentially increasing its activity as part of the PKC signal transduction cascade. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels which can lead to activation of calcium-dependent proteins and pathways that could enhance the activity of p60TRP through calcium signaling mechanisms. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore that raises intracellular calcium levels and may activate calcium-dependent kinases, which in turn could increase the activity of p60TRP within calcium-mediated signaling pathways. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
β-adrenergic agonist that increases cAMP levels by stimulating adenylyl cyclase, thereby potentially enhancing p60TRP activity via PKA-dependent mechanisms. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
L-type calcium channel agonist that increases calcium influx, potentially activating p60TRP through downstream calcium-dependent signaling processes. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor that leads to an increase in cytosolic calcium levels, which could indirectly increase p60TRP activity through calcium-dependent signaling. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Inhibits protein synthesis and also activates the MAPK pathway, which may lead to an indirect increase in p60TRP activity as part of the stress response signaling. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
PKC inhibitor that can lead to compensatory regulatory mechanisms within the PKC pathway potentially resulting in increased activity of p60TRP as part of the cellular feedback response. | ||||||